| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $949.2M | +7.7% |
| Cost of Revenue | $527.7M | +9.5% |
| Gross Profit | $421.5M | +5.4% |
| R&D Expense | $95.5M | +4.2% |
| SG&A Expense | $175.9M | +7.0% |
| Operating Income | $110.6M | +0.1% |
| Pre-tax Income | $79.1M | -5.6% |
| Income Tax | $15.0M | +37.8% |
| Net Income | $64.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $114.0M | +8.5% |
| Accounts Receivable | $151.0M | +8.3% |
| Inventory | $144.6M | -3.2% |
| Current Assets | $433.6M | +4.4% |
| Total Assets | $1.39B | +13.3% |
| Current Liabilities | $167.8M | +20.6% |
| Long-term Debt | $411.9M | +17.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $158.5M | +32.0% |
| Capital Expenditures | $17.2M | -14.0% |
| Investing Cash Flow | -$208.2M | -946.6% |
| Financing Cash Flow | $56.9M | +158.2% |
| Free Cash Flow | $141.3M | +41.2% |
| -12.1% |
| EPS (Basic) | $1.78 | -12.3% |
| EPS (Diluted) | $1.77 | -12.4% |
| Total Liabilities |
| $642.8M |
| +16.3% |
| Stockholders' Equity | $745.7M | +10.7% |